Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Recruiting · NCT05815927 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | Oligometastatic Squamous Cell Carcinoma of the Head and Neck | Recruiting | Phase 3 | 2026-05-28 | NCT05815927 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 54 |
| Merck Sharp & Dohme LLC | 650 |
| Swiss Cancer Institute | 29 |
30 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.